(S1 (S (S (NP (NP (JJ Epidermal) (NN growth) (NN factor)) (CC and) (NP (PRP$ its) (NN receptor)))) (. .)))
(S1 (S (S (NP (NP (JJ Epidermal) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN EGF)) (-RRB- -RRB-))) (VP (VBZ binds) (PP (IN with) (NP (NP (JJ high) (NN affinity)) (CC and) (NP (NN specificity)))) (PP (TO to) (NP (NP (DT a) (JJ single) (NN site)) (PP (IN on) (NP (NP (DT the) (JJ external) (NN domain)) (PP (IN of) (NP (PRP$ its) (NN transmembrane) (NN receptor))) (S (VP (TO to) (VP (VB activate) (NP (NP (DT the) (NP (NN tyrosine) (NN protein) (NN kinase)) (NN activity)) (PP (IN of) (NP (PRP$ its) (JJ cytoplasmic) (NN portion))))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN EGF) (NN receptor) (NN gene)) (VP (VBZ is) (VP (VP (VBN amplified)) (CC and) (VP (VBN over-expressed) (PP (IN in) (NP (JJ several) (JJ human) (NNS tumors))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (VBN increased) (NNS concentrations)) (PP (IN of) (NP (DT the) (NN proto-oncogene)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ constitutive) (NN activity)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN with) (NP (NN oncogene) (NN erb) (NN B)))))))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN Synthesis)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (DT the) (NN EGF) (NN receptor)))) (VP (VBP are) (VP (VBN regulated) (, ,) (PP (IN in) (NP (NN addition))) (, ,) (NP (NP (JJ covalent) (NN modification)) (SBAR (IN by) (S (NP (NN phosphorylation)) (VP (VBZ regulates) (NP (NP (NN activity)) (PP (IN of) (NP (DT the) (NN receptor) (NN protein))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Intramolecular) (NN self-phosphorylation)) (PP (IN of) (NP (NN Tyr1173)))) (VP (VBZ removes) (NP (NP (DT a) (JJ competitive) (JJ inhibitory) (NN constraint)) (S (VP (TO to) (VP (VB enhance) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NNS substrates)))))))))) (. .)))
(S1 (S (S (NP (NP (NN Phosphorylation)) (PP (IN of) (NP (NN Thr654))) (PP (IN by) (NP (NN protein) (NN kinase) (NN C)))) (VP (VBZ decreases) (NP (NP (JJ high) (NN affinity) (NN EGF) (NN binding)) (CC and) (NP (NP (JJ EGF-stimulated) (NN tyrosine) (NN protein) (NN kinase)) (NN activity))) (, ,) (S (VP (VBG providing) (NP (NP (DT a) (NN mechanism)) (PP (IN for) (NP (NP (JJ heterologous) (NN regulation)) (PP (IN of) (NP (DT the) (NN EGF) (NN receptor))) (PP (IN by) (NP (NP (NN tumor) (NNS promoters)) (CC and) (NP (JJ other) (NN ligand) (NN X) (NN receptor) (NNS complexes))))))))))) (. .)))
(S1 (S (S (NP (JJ Extensive) (NN regulation)) (VP (VBZ contributes) (PP (TO to) (NP (JJ normal) (NN growth) (NN control))))) (, ,) (S (NP (NP (NN abrogation)) (PP (IN of) (NP (JJ regulatory) (NNS controls)))) (VP (VBZ contributes) (PP (TO to) (NP (JJ uncontrolled) (NN growth))) (SBAR (IN as) (S (VP (VBN seen) (PP (IN with) (NP (NP (NP (NN erb) (NN B) (NN transformation)) (CC and) (NP (NN EGF) (NN receptor) (NN gene) (NN amplification))) (PP (IN in) (NP (JJ human) (NNS tumors)))))))))) (. .)))
